Open Call for Patient Input for a new Joint Assessment on a medicinal product for the prevention of vaso-occlusive crises in sickle cell disease (SCD) patients aged 16 years and over.
Patient group input requested for a new Joint Assessment on a medicinal product for the prevention of vaso-occlusive crises in sickle cell disease (SCD) patients aged 16 years and over. EUnetHTA deems patient involvement very important in the production of
OTCA19 – ”Screening for osteoporosis in the general population” final assessment and related documentation is now available
EUnetHTA is pleased to announce that the final project plan, final assessment, comments from the external experts and authors' answers, together with the final abstract and plain language summary for OTCA19 "Screening for osteoporosis in the general population'' are now
The public consultation of the draft methodological guideline “Practical considerations when critically assessing economic evaluations” is OPEN (deadline Oct. 11, 2019)
We are pleased to announce that, as of today, the draft methodological guideline "Practical considerations when critically assessing economic evaluations", produced within WP6 B2, has entered the public consultation phase. This consultation will be open until 11th October, 2019. Objective of the
Open Call for Patient Input for a new Joint Assessment on a medicinal product for severe Gram-negative (bacterial) infections.
Patient group input requested for a new Joint Assessment on a medicinal product for severe Gram-negative (bacterial) infections. EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them